| abstract |
The invention relates to other methods for determining the level of antipsychotic agents, in particular to the prescribing physician's clinic (so that treatment for individual patients can be adjusted more rapidly), and Providing methods that can be performed in other medical settings that lack LC or GC / MS equipment or require rapid test results. Disclosed is an antibody that binds quetiapine, which can be used to detect quetiapine in a sample, such as in a competitive immunoassay method. The antibodies can be used in lateral flow assay devices for point-of-care detection of quetiapine, including multiplex detection of aripiprazole, olanzapine, quetiapine, and risperidone in a single lateral flow assay device. 【Selection chart】 None |